Glenmede Trust CO Na Boston Scientific Corp Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Boston Scientific Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 20,463 shares of BSX stock, worth $1.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,463

Previous 17,202 18.96%

Holding current value

$1.86 Million

Previous $1.32 Million 29.46%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $237,922 - $273,924	3,261 Added 18.96%	20,463 $1.71 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $71,504 - $82,528	1,062 Added 6.58%	17,202 $1.32 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $65,145 - $77,609	1,131 Added 7.54%	16,140 $1.11 Million
Q4 2023 Feb 13, 2024	BUY	$48.64 - $57.81 $222,138 - $264,018	4,567 Added 43.74%	15,009 $867,000
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $56,363 - $61,405	1,123 Added 12.05%	10,442 $551,000
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $41,618 - $46,177	923 Added 10.99%	9,319 $466,000
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $26,070 - $31,117	-659 Reduced 7.28%	8,396 $388,000
Q3 2022 Nov 16, 2022	BUY	$36.71 - $109.66 $332,409 - $992,971	9,055 New	9,055 $349,000
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $218,452 - $291,972	-6,199 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $40,000 - $44,107	-978 Reduced 13.63%	6,199 $274,000
Q4 2021 Feb 15, 2022	BUY	$38.07 - $44.87 $30,151 - $35,537	792 Added 12.4%	7,177 $304,000
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $1,278 - $1,422	31 Added 0.49%	6,385 $276,000
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $14,120 - $16,191	-366 Reduced 5.45%	6,354 $270,000
Q1 2021 May 18, 2021	BUY	$35.27 - $39.67 $30,825 - $34,671	874 Added 14.95%	6,720 $259,000
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $151,429 - $191,718	-4,568 Reduced 43.86%	5,846 $209,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $11,020 - $13,513	320 Added 3.17%	10,414 $397,000
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $138,360 - $179,241	4,583 Added 83.16%	10,094 $353,000
Q4 2019 Feb 12, 2020	SELL	$37.87 - $45.37 $10,906 - $13,066	-288 Reduced 4.97%	5,511 $249,000
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $42,930 - $46,274	1,065 Added 22.5%	5,799 $235,000
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $43,148 - $53,123	-1,236 Reduced 20.7%	4,734 $202,000
Q1 2019 May 14, 2019	BUY	$32.91 - $40.75 $1,711 - $2,119	52 Added 0.88%	5,970 $228,000
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $187,778 - $231,038	5,918 New	5,918 $208,000
Q3 2018 Nov 15, 2018	SELL	$32.83 - $38.63 $129,744 - $152,665	-3,952 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$26.84 - $34.32 $543,187 - $694,568	-20,238 Reduced 83.66%	3,952 $129,000
Q4 2017 Feb 15, 2018	SELL	$24.79 - $29.8 $11,279 - $13,559	-455 Reduced 1.85%	24,190 $598,000
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $647,177 - $718,894	24,645	24,645 $0

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Boston Scientific Corp Transaction History